Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis

International Journal of Rheumatic Diseases

Volumn 18, Issue 3, 2015, Pages 352-359

  Paosong, Suangkanok ^a   Narongroeknawin, Pongthorn ^a   Pakchotanon, Rattapol ^a   Asavatanabodee, Paijit ^a   Chaiamnuay, Sumapa ^a  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

Diagnosis; High sensitivity C reactive protein; Procalcitonin; Septic arthritis

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; AUTACOID; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL ARTHRITIS; BLOOD CELL COUNT; BLOOD SAMPLING; CELL COUNT; COMPARATIVE STUDY; CONCURRENT INFECTION; CROSS-SECTIONAL STUDY; CRYSTAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; GRAM STAINING; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; ACUTE DISEASE; ADULT; ARTHRITIS, INFECTIOUS; BACTERIUM; BLOOD; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EVALUATION STUDY; FEMALE; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; UPREGULATION; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ARTHRITIS, INFECTIOUS; BACTERIA; BACTERIOLOGICAL TECHNIQUES; BIOMARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; UP-REGULATION;

EID: 84928583663     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12496     Document Type: Article

References (22)

1. Marker-Hermann E (2008) Septic arthritis, osteomyelitis, gonococcal and syphilitic arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman ME, eds. Rheumatology. Vol 2. 4th edn, pp 1013-28. Elsevier Limited, Spain.
2. Seligman R, Ramos-Lima LF, Oliveira VA, Sanvicente C, Pacheco EF, Dalla Rosa K (2012) Biomarkers in community-acquired pneumonia: a state-of-the-art review. Clinics (Sao Paulo) 67, 1321-5.
3. Muller B, Becker KL, Schachinger H et al. (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28, 977-83.
4. Becker KL, Snider R, Nylen ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159, 253-64.
5. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89, 1512-25.
6. Newman JH (1976) Review of septic arthritis throughout the antibiotic era. Ann Rheum Dis 35, 198-205.
7. American College of Chest Physicians/Society of Critical Care (1992) Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20, 864-74.
8. Hugle T, Schuetz P, Mueller B et al. (2008) Serum procalcitonin for discrimination between septic and non-septic arthritis. Clin Exp Rheumatol 26, 453-6.
9. Fottner A, Birkenmaier C, van Schulze Pellengahr C, Wegener B, Jansson V (2008) Can serum procalcitonin help to differentiate between septic and nonseptic arthritis? Arthroscopy 24 229-33.
10. Talebi-Taher M, Shirani F, Nikanjam N, Shekarabi M (2013) Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers. Rheumatol Int 33, 319-24.
11. Lorrot M, Fitoussi F, Faye A et al. (2007) Laboratory studies in pediatric bone and joint infections. Arch Pediatr 14 (Suppl 2), S86-90.
12. Soderquist B, Jones I, Fredlund H, Vikerfors T (1998) Bacterial or crystal-associated arthritis? Discriminating ability of serum inflammatory markers. Scand J Infect Dis 30, 591-6.
13. Shen CJ, Wu MS, Lin KH et al. (2013) The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis 32, 807-14.
14. Martinot M, Sordet C, Soubrier M et al. (2005) Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients. Clin Exp Rheumatol 23, 303-10.
15. Streit G, Alber D, Toubin MM, Toussirot E, Wendling D (2008) Procalcitonin, C-reactive protein, and complement-3a assays in synovial fluid for diagnosing septic arthritis: preliminary results. Joint Bone Spine 75, 238-9.
16. Muller B, Christ-Crain M, Nylen ES, Snider R, Becker KL (2004) Limits to the use of the procalcitonin level as a diagnostic marker. Clin Infect Dis 39, 1867-8.
17. Kibe S, Adams K, Barlow G (2011) Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 66(Suppl 2), ii33-40.
18. Polzin A, Pletz M, Erbes R et al. (2003) Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis. Eur Respir J 21, 939-43.
19. Boussekey N, Leroy O, Georges H, Devos P, d'Escrivan T, Guery B (2005) Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 33, 257-63.
20. Christ-Crain M, Stolz D, Bingisser R et al. (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174 (1), 84-93.
21. Butbul-Aviel Y, Koren A, Halevy R, Sakran W (2005) Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care 21, 828-32.
22. Faesch S, Cojocaru B, Hennequin C et al. (2009) Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial. Ital J Pediatr 35 (1), 33.